Policy and Advocacy Events at Neuroscience 2014
Organizer/Moderator: Michael E. Goldberg, MD
Date & Time: Tuesday, November 18, 12-2 p.m.
Panelists: Richard Cupp, JD; Patricia Foley, DVM; Wendy Jarrett; Jeff Kordower, PhD
Yesterday's terrorism tactics have given way to a new breed of activism, with implications for all researchers that work with animal models. Today's tactics include misuse of governmental and regulatory processes. This not only drives up the cost of research but forces researchers out of the lab to respond to unfounded claims. These tactics also undermine the legitimate role of a strong regulatory framework. This panel will explore the global implications for biomedical research and how this new breed of activism impacts scientists.
Organizer/Moderator: Anne Young, MD, PhD
Date & Time: Tuesday, November 18, 3-5 p.m.
Panelists: Sarah J. Caddick, PhD; Miyoung Chun, PhD; William T. Newsome, PhD; Hideyuki Okano, MD, PhD
Neuroscience has been identified as a priority through initiatives in the US, Europe, Asia, and other projects around the globe. In an era flat or declining budgets for biomedical research, what impact will these large-scale projects have throughout the field? What will be the role of private funding for these and other initiatives? How will these projects and the way they are funded affect individual research projects, primary investigators, universities, businesses, and science as a whole?
Chair: Story Landis, PhD
Co-Chair: Thomas Insel, MD
Date & Time: Sunday, November 16, 8:30-11 a.m.
Location: Ballroom A
There are growing concerns about the reproducibility of life science research results and the impact that these concerns could have on neuroscience. The presentations in this symposium will summarize common causes of poor reproducibility, describe actions taken by NIH and journals to improve reliability, offer investigator perspectives, and address relevance for training. A panel discussion will follow that will take questions from the audience.
Empirical Approaches to Neuroscience and Society Symposium: Improving Animal Models of Neuropsychiatric Disorders
Chair: Trevor W. Robbins, PhD
Date & Time: Saturday, November 15, 1:30-4 p.m.
Location: Ballroom A
The relative lack of success of big pharma in producing new drugs for psychiatric disorders has focused attention in part on improving animal models. This symposium focuses on recent examples of innovative molecular, genetic, and behavioral approaches to animal models of schizophrenia and depression. The symposium also will provide an industrial perspective and suggest new ways of advancing collaboration and development of this field to achieve more effective translation to the clinic.
Organizer/Moderator: Jonathan Moreno, PhD
Date & Time: Sunday, November 16, 1-3 p.m.
Speakers: Martha J. Farah, PhD; Adam Gazzaley, MD, PhD; Daniel Greenberg; Mark Griffiths, PhD
Countless number of people from all demographics use electronic games daily, but are mostly unaware how programmers use neuroscience concepts into the game designs. Organized by the Institute of Medicine Neuroscience Forum, this roundtable will explore the use of neuroscience in gaming, with an emphasis on scientific, ethical, and societal issues. Participants will explore design features derived from neuroscience concepts while considering both the positive and negative implications of the use of neuroscience in design. Finally, the roundtable will discuss potential ethical implications and policy outcomes that may protect gamers from design features that may have negative outcomes.